IP Library Granted Patent US 6,987,002
Granted Patent B2
US 6,987,002 · App. 09/938,334 · Granted Jan 17, 2006

Composition for detecting β-1,3-glucan

Assignee: Samyang Genex Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,987,002
App. No.
09/938,334
Granted
Jan 17, 2006
Kind
B2
Abstract

The present invention relates to a composition for detecting an infinitesimal quantity of β-1,3-glucan, a preparation method thereof and a diagnostic kit detecting β-1,3-glucan. The composition of the present invention shows phenoloxidase activity by β-1,3-glucan in the presence of calcium ions. Using the composition of the present invention, a sample is gathered from a specimen, the composition of the present invention and calcium ions are added to the sample, and β-1,3-glucan is detected by measuring phenoloxidase activity.

Claims (10)

1. A composition for detecting β-1,3-glucan in the presence of calcium ions, prepared by the method comprising:

(i) collecting a sample comprising a mixture of plasma and hemocyte lysate from Tenebrio molitor or Holotrichia diomphalia;

(ii) purifying said sample by column chromatography using a solvent or buffer solution containing a sufficient amount of a chelating agent to chelate calcium ions present in said sample to obtain fractions therefrom; and

(iii) selecting fractions exhibiting phenoloxidase activity by β-1,3-glucan in the presence of calcium ions from the obtained fractions.

2. A composition for detecting β-1,3-glucan according to claim 1 wherein the composition detects β-1,3-glucan concentrations as low as 20 pg/ml in the presence of calcium ions.

3. A composition for detecting β-1,3-glucan exhibiting phenoloxidase activity by β-1,3-glucan in the presence of calcium ions, said composition prepared by:

(i) treating Tenebric molitor or Holotrichia diomphalia plasma with a solvent or buffer solution containing a sufficient amount of a chelating agent to chelate calcium ions present in the plasma and

(ii) separating said chelated plasma by chromatography to obtain fractions from said chelated plasma;

(iii) adding hemocyte lysate or partially purified hemocyte lysate to said fractions to form lysate treated fractions, and

(iv) selecting lysate treated fractions exhibiting phenoloxidase activity by β-1,3-glucan in the presence of calcium ions.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2014
From: SAMYANG GENEX CORPORATION
To: SAMYANG BIOPHARMACEUTICALS CORPORATION
Reel/Frame 032666/0518 →
CORRECTIVE ASSIGNMENT TO ADD TWO ASSIGNORS TO THE DOCUMENT PREVIOUSLY RECORDED ON REEL 012342, FRAME 0766. ASSIGNOR HEREBY CONFIRMS THE ASSIGNMENT OF THE ENTIRE INTEREST. Recorded Mar 12, 2002
From: AUH, JOONG HYUCK; PARK, BU SOO; JOO, CHANG HUN; PARK, CHONG JIN; LEE, BOK LUEL; LEE, KUM YOUNG; HONG, SEUNG-SUH; LEE, HYUN-SOO
To: SAMYANG GENEX CORPORATION
Reel/Frame 012688/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2001
From: AUH, JOONG HYUCK; PARK, BU SOO; JOO, CHANG HUN; PARK, CHONG JIN; LEE, BOK LUEL; LEE, KUM YOUNG
To: SAMYANG GENEX CORPORATION
Reel/Frame 012342/0766 →
Priority Claims (1)
KR 2000-2542 · Jan 20, 2000 · national
Continuity (2)
Continuation PCTKR010010600 · Jan 20, 2001
Related Publication 20020197662A1 · Dec 26, 2002